Mylan’s Floating Rate Senior Debt Offering

Cravath represented Mylan N.V. in connection with its €500 million Reg. S floating rate senior debt offering. Mylan N.V. is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The notes were listed on the Irish Stock Exchange. The transaction closed on May 24, 2017.

The Cravath team included partner William V. Fogg and associates Benjamin S. Persina, Martin P. Pepeljugoski and Justin B. Stein.